Blocking of interleukin-10 receptor - A novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus

Clinical Immunology

Volumn 117, Issue 1, 2005, Pages 57-64

  Rigopoulou, Eirini I ^a,b   Abbott, William G H ^a   Haigh, Philip ^a   Naoumov, Nikolai V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Chronic hepatitis C; Cytokines; IFN ; IL 10; Immunotherapy; T cells; Th1 Th2 profile

Indexed keywords

CD4 ANTIGEN; CORE PROTEIN; GAMMA INTERFERON; HEPATITIS C ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3C5 2; MONOCLONAL ANTIBODY 3F9; NON STRUCTURAL PROTEIN 4; NONSTRUCTURAL PROTEIN 3; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; INTERLEUKIN RECEPTOR;

ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL SPECIFICITY; CELLULAR IMMUNITY; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; RECEPTOR BLOCKING; T LYMPHOCYTE; TH1 CELL; VIRUS CORE; VIRUS IMMUNITY; BIOSYNTHESIS; CELL PROLIFERATION; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; MIDDLE AGED; VIROLOGY;

ADULT; ANTIBODIES, MONOCLONAL; CELL PROLIFERATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10; TH1 CELLS;

EID: 27244444359     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.06.003     Document Type: Article

References (39)

1. H.M. Diepolder, R. Zachoval, R.M. Hoffmann, E.A. Wierenga, T. Santantonio, M.C. Jung, D. Eichenlaub, and G.R. Pape Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection Lancet 346 1995 1006 1007
2. G. Missale, R. Bertoni, V. Lamonaca, A. Valli, M. Massari, C. Mori, M.G. Rumi, M. Houghton, F. Fiaccadori, and C. Ferrari Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J. Clin. Invest. 98 1996 706 714
3. J.T. Gerlach, H.M. Diepolder, M.C. Jung, N.H. Gruener, W.W. Schraut, R. Zachoval, R. Hoffmann, C.A. Schirren, T. Santantonio, and G.R. Pape Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C Gastroenterology 117 1999 933 941
4. F. Lechner, D.K. Wong, P.R. Dunbar, R. Chapman, R.T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B.D. Walker Analysis of successful immune responses in persons infected with hepatitis C virus J. Exp. Med. 191 2000 1499 1512
5. R. Thimme, D. Oldach, K.M. Chang, C. Steiger, S.C. Ray, and F.V. Chisari Determinants of viral clearance and persistence during acute hepatitis C virus infection J. Exp. Med. 194 2001 1395 1406
6. S. Cooper, A.L. Erickson, E.J. Adams, J. Kansopon, A.J. Weiner, D.Y. Chien, M. Houghton, P. Parham, and C.M. Walker Analysis of a successful immune response against hepatitis C virus Immunity 10 1999 439 449
7. R. Thimme, J. Bukh, H.C. Spangenberg, S. Wieland, J. Pemberton, C. Steiger, S. Govindarajan, R.H. Purcell, and F.V. Chisari Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease Proc. Natl. Acad. Sci. U. S. A. 99 2002 15661 15668
8. M.E. Cramp, P. Carucci, S. Rossol, S. Chokshi, G. Maertens, R. Williams, and N.V. Naoumov Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia Gut 44 1999 424 429
9. A. Takaki, M. Wiese, G. Maertens, E. Depla, U. Seifert, A. Liebetrau, J.L. Miller, M.P. Manns, and B. Rehermann Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nat. Med. 6 2000 578 582
10. S.L. Tsai, Y.F. Liaw, M.H. Chen, C.Y. Huang, and G.C. Kuo Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity Hepatology 25 1997 449 458
11. T.V. Cacciarelli, O.M. Martinez, R.G. Gish, J.C. Villanueva, and S.M. Krams Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa Hepatology 24 1996 6 9
12. M. Reiser, C.G. Marousis, D.R. Nelson, G. Lauer, R.P. Gonzalez-Peralta, G.L. Davis, and J.Y. Lau Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection J. Hepatol. 26 1997 471 478
13. M. Lechmann, R.P. Woitas, B. Langhans, R. Kaiser, H.G. Ihlenfeldt, G. Jung, T. Sauerbruch, and U. Spengler Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C J. Hepatol. 31 1999 971 978
14. A. Godkin, N. Jeanguet, M. Thursz, P. Openshaw, and H. Thomas Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients Eur. J. Immunol. 31 2001 1438 1446
15. K.W. Moore, M.R. de Waal, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu. Rev. Immunol. 19 2001 683 765
16. Y. Liu, S.H. Wei, A.S. Ho, M.R. de Waal, and K.W. Moore Expression cloning and characterization of a human IL-10 receptor J. Immunol. 152 1994 1821 1829
17. J.C. Tan, S. Braun, H. Rong, R. DiGiacomo, E. Dolphin, S. Baldwin, S.K. Narula, P.J. Zavodny, and C.C. Chou Characterization of recombinant extracellular domain of human interleukin-10 receptor J. Biol. Chem. 270 1995 12906 12911
18. M.E. Cramp, S. Rossol, S. Chokshi, P. Carucci, R. Williams, and N.V. Naoumov Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C Gastroenterology 118 2000 346 355
19. Y. Liu, M.R. de Waal, F. Briere, C. Parham, J.M. Bridon, J. Banchereau, K.W. Moore, and J. Xu The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor J. Immunol. 158 1997 604 613
20. F. Payvandi, S. Amrute, and P. Fitzgerald-Bocarsly Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation J. Immunol. 160 1998 5861 5868
21. S.E. Macatonia, T.M. Doherty, S.C. Knight, and A. O'Garra Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production J. Immunol. 150 1993 3755 3765
22. T.R. Mosmann, and K.W. Moore The role of IL-10 in crossregulation of TH1 and TH2 responses Immunol. Today 12 1991 A49 A53
23. D.F. Fiorentino, A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra IL-10 inhibits cytokine production by activated macrophages J. Immunol. 147 1991 3815 3822
24. M. Clerici, T.A. Wynn, J.A. Berzofsky, S.P. Blatt, C.W. Hendrix, A. Sher, R.L. Coffman, and G.M. Shearer Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus J. Clin. Invest. 93 1994 768 775
25. P. McGuirk, C. McCann, and K.H. Mills Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis J. Exp. Med. 195 2002 221 231
26. F. Gerosa, C. Nisii, S. Righetti, R. Micciolo, M. Marchesini, A. Cazzadori, and G. Trinchieri CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients Clin. Immunol. 92 1999 224 234
27. M.L. Murphy, U. Wille, E.N. Villegas, C.A. Hunter, and J.P. Farrell IL-10 mediates susceptibility to Leishmania donovani infection Eur. J. Immunol. 31 2001 2848 2856
28. S.M. Kamal, J.W. Rasenack, L. Bianchi, T.A. Al, K.K. El Sayed, T. Peter, H. Mansour, W. Ezzat, and M. Koziel Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response Gastroenterology 121 2001 646 656
29. D.R. Nelson, Z. Tu, C. Soldevila-Pico, M. Abdelmalek, H. Zhu, Y.L. Xu, R. Cabrera, C. Liu, and G.L. Davis Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect Hepatology 38 2003 859 868
30. A. Dolganiuc, K. Kodys, A. Kopasz, C. Marshall, T. Do, L. Romics Jr., P. Mandrekar, M. Zapp, and G. Szabo Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation J. Immunol. 170 2003 5615 5624
31. A.J. MacDonald, M. Duffy, M.T. Brady, S. McKiernan, W. Hall, J. Hegarty, M. Curry, and K.H. Mills CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons J. Infect. Dis. 185 2002 720 727
32. M.T. Brady, A.J. MacDonald, A.G. Rowan, and K.H. Mills Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes Eur. J. Immunol. 33 2003 3448 3457
33. M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman, R. Reindollar, Z.D. Goodman, K. Koury, M. Ling, and J.K. Albrecht Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965
34. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, F.L. Goncales Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N. Engl. J. Med. 347 2002 975 982
35. S.M. Kamal, J. Fehr, B. Roesler, T. Peters, and J.W. Rasenack Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C Gastroenterology 123 2002 1070 1083
36. H.W. Murray, C.M. Lu, S. Mauze, S. Freeman, A.L. Moreira, G. Kaplan, and R.L. Coffman Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy Infect. Immun. 70 2002 6284 6293
37. R.A. Silva, and R. Appelberg Blocking the receptor for interleukin 10 protects mice from lethal listeriosis Antimicrob. Agents Chemother. 45 2001 1312 1314
38. R.A. Silva, T.F. Pais, and R. Appelberg Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination J. Immunol. 167 2001 1535 1541
39. J. Eskdale, G. Gallagher, C.L. Verweij, V. Keijsers, R.G. Westendorp, and T.W. Huizinga Interleukin 10 secretion in relation to human IL-10 locus haplotypes Proc. Natl. Acad. Sci. U. S. A. 95 1998 9465 9470